Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

November was another volatile month for biotech stocks. In the latter part of themonth the new COVID mutation, Omicron, was discovered in South Africa which created new uncertainty and lockdowns around the globe. BB Biotech's  portfolio ended the month in negative territory. Despite the macro instability we remain focused on our investments in fast-growing biotech companies that are developing and marketing drugs for unmetmedical needs.<br />

BB Biotech Update November 2021

November was another volatile month for biotech stocks. In the latter part of themonth the new COVID mutation, Omicron, was discovered in South Africa which created new uncertainty and lockdowns around the globe. BB Biotech's portfolio ended the month in negative territory. Despite the macro instability we remain focused on our investments in fast-growing biotech companies that are developing and marketing drugs for unmetmedical needs.
09.12.2021 - BB Biotech